(USD) | Nov 2023 | Q/Q |
---|---|---|
Revenue | 14.5MM | -7% |
Gross Profit | 9.8MM | -20% |
Cost Of Revenue | 4.7MM | +38% |
Operating Income | 960K | -438% |
Operating Expenses | 8.9MM | -29% |
Net Income | 1.9MM | - |
R&D | 1.2MM | +13% |
G&A | 5.7MM | -56% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
LANCASTER, Calif., March 20, 2024--Simulations Plus will hold a conference call to discuss the Company's 2nd quarter FY24 financial results on Wed, April 3, 2024, at 5pm EDT.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
LANCASTER, Calif., March 13, 2024--Simulations Plus CEO, Shawn O'Connor, will be presenting at KeyBanc Capital Markets Virtual Investor Forum on March 20, 2024, at 4:30 p.m. EDT.
Walter Woltosz, a director and 10% owner of Simulations Plus Inc (NASDAQ:SLP), sold 20,000 shares of the company on March 1, 2024, according to a recent SEC filing.
LANCASTER, Calif., March 05, 2024--Simulations Plus with university partners was awarded a new FDA grant to expand and validate PBBM/PBPK modeling solutions for topical products.
LANCASTER, Calif., February 15, 2024--Simulations Plus today announced an extension to its agreement with the NIEHS Division of Translational Toxicology to support their research efforts.
LANCASTER, Calif., February 13, 2024--Simulations Plus today announced the launch of a corporate development initiative to pursue strategic investments in early-stage technology companies.
Key Insights Using the 2 Stage Free Cash Flow to Equity, Simulations Plus fair value estimate is US$33.35 With US$38.54...
LANCASTER, Calif., February 06, 2024--Simulations Plus will be participating in Oppenheimer's 34th Annual Healthcare Life Sciences Conference and BTIG at Snowbird on February 13-14, 2024.
On February 2, 2024, Walter Woltosz, Director and 10% Owner of Simulations Plus Inc (NASDAQ:SLP), sold 20,000 shares of the company's stock, according to a recent SEC Filing.